GLP-1消费者研究报告

The GLP-1 Consumer The most comprehensive analysis of GLP-1 users todate, based on 58,008 surveys. Executive Summary GLP-1 medications have moved from niche diabetes treatments to mainstreamcultural phenomena. This report answers two core questions:who are GLP-1 users,and what do their behaviors and preferences mean for brands? The brand-consideration data, covering 3,081 brands, reveals thatGLP-1 users showhigher purchasing consideration for 99.9% of all brands measured, with an averageuplift of +12.9 percentage points. The audience-profile data, based on 58,008 U.S.adults, explains why: GLP-1 users are wealthier, better educated, more digitallyengaged, more socially active, more politically engaged, and more optimistic aboutthe economy than the average American. The result is a consumer archetype that defies easy categorization. GLP-1 users aresimultaneously health-conscious and impulsive, status-driven and community-oriented, disciplined about food and enthusiastic about indulgent brands. They arenot a health niche—they are an affluent, hyper-engaged, aspirational consumersegment that happens to manage weight with modern pharmaceuticals. And as GLP-1prescriptions continue their rapid growth, this segment will only become morecommercially important. Key Takeaways 1.GLP-1 users are markedly more affluent and educatedthan the generalpopulation.The share earning over $100,000 is 31% (+17pp compared to alladults). 2.They are far more engaged with novelty, status, and social currencythan theaverage adult. These are consumers primed for premium products, limitededitions, and brand storytelling that appeals to aspiration and belonging. 3.The ”impulsive health-conscious paradox”is perhaps the most revealingtension in the data. 49% of GLP-1 users “tend to be impulsive” (vs. 38% of alladults), yet 74% say health is their primary food decision factor (vs. 63%). Thisparadox resolves when you understand GLP-1 users as active managers ofcompeting impulses. 4.There is a near-universal uplift in purchasing for brands:GLP-1 users showhigher purchasing consideration for 3,077 of 3,081 brands measured. Theaverage uplift is +12.9 pp. 5.GLP-1 users show elevated interest in luxury and aspirational brands.Lincoln(+27.8), Rolex (+25.4), and Mercedes-Benz (+25.3) all appear in the top tier. Thisis the behavioral expression of the audience’s self-reported desire to “live alifestyle that impresses others” (+14 pp). 6.Coca-Cola Zero Sugar is the standout brand(not including GLP-1 medicationbrands) in terms of purchasing consideration. More broadly, the most strikingcluster of elevated consideration belongs to zero-sugar and diet beverages. Want to understand what GLP-1 usersthink about your brand and category? Data featured in this report comes fromMorning Consult Intelligence, the Always OnConsumer Signal. The platform helps you understand your audience, brand, competitors andmarket in a way traditional research companies can’t. Demographic foundations The demographic profile of GLP-1 users departs sharply from the general adult populationacross age, household composition, geography, education, and income. Gen X is the coregenerational cohort (35% vs. 25%, +10 pp), with Millennials also over-represented (31% vs.28%). Boomers (−7 pp) and Gen Z (−3 pp) are under-represented. The audience is overwhelmingly married (57% vs. 41%, +16 pp) and far more likely to havechildren at home (45% vs. 27%, +18 pp). They skew urban (41% vs. 28%, +13 pp), and disproportionately white (85% vs. 78%). Education, Income, and Wealth GLP-1 users are markedly more affluent and educatedthan the general population.Theshare earning over $100,000 is more than double (31% vs. 14%, +17 pp), while the under-$50,000 bracket shrinks by 18 percentage points. Educational attainment follows the sametrajectory: 27% hold a master’s degree or above, versus just 12% of all adults (+15 pp). Investment holdings reinforce the picture. The share with $50,000 or more invested is 42%versus 25% (+17 pp), and within higher investment brackets, GLP-1 users are notably moreconcentrated in the $500k–$1M range (22% vs. 15%, +7 pp). Nearly all are insured (96% vs.86%), most through employer-sponsored plans (39% vs. 32%)—a practical prerequisite foraffording GLP-1 medications, which can cost over $1,000 per month without coverage. Early Adopters, Trend Seekers,Status Strivers The psychographic data reveals a consumer far more engaged with novelty, status, andsocial currency than the average adult. GLP-1 users are +15 pp more likely to be among thefirst to try new technology (46% vs. 31%), +15 pp more likely to follow the latest trends (47%vs. 32%), and +14 pp more likely to want a lifestyle that impresses others (35% vs. 21%).They are +12 pp more likely to strive for high social status and +13 pp more likely to say thatbeing part of the popular crowd matters. These are consumers primed for premium products, limited editions, and brandstorytelling that appeals to